Warp speed goin' to stall out? - not enough vaccine to go around.
#1
Senior Member
Thread Starter
Join Date: Aug 2009
Location: Minneapolis
Posts: 3,644
Bikes: 2020 Salsa Warbird GRX 600, 2020 Canyon Ultimate CF SLX disc 9.0 Di2, 2020 Catrike Eola, 2016 Masi cxgr, 2011, Felt F3 Ltd, 2010 Trek 2.1, 2009 KHS Flite 220
Mentioned: 15 Post(s)
Tagged: 0 Thread(s)
Quoted: 2467 Post(s)
Liked 1,463 Times
in
881 Posts
Warp speed goin' to stall out? - not enough vaccine to go around.
Maybe this belongs in P&R?
So, Warp Speed contracted with Pfizer to buy 100 million doses, and with Moderna to buy another 100 million. Vaccination takes 2 doses/person, so that will vaccinate less than a third of the country. 100 million vaccinated, 225 million left waiting?
And in August, when Pfizer offered more, the Trump Administration declined to purchase them.
(see also Forbes story on same topic)
It seems that the EU has purchase the available supplies instead.
Spokesperson at Health and Human Services says
"We are confident that we will have 100 million doses of Pfizer’s vaccine as agreed to in our contract,” a spokesperson for Health and Human Services told Forbes, “and beyond that, we have five other vaccine candidates, including 100 million doses on the way from Moderna.”"
Other vaccine candidates? Which of these are likely to be anywhere near approval in the next few months?
Secretary Azar says that there will be enough vaccine for everybody in the second quarter of 2021
but no word on sources and supplies beyond the 100 million people (200 million doses) already contracted.
Discouraging.
So, Warp Speed contracted with Pfizer to buy 100 million doses, and with Moderna to buy another 100 million. Vaccination takes 2 doses/person, so that will vaccinate less than a third of the country. 100 million vaccinated, 225 million left waiting?
And in August, when Pfizer offered more, the Trump Administration declined to purchase them.
(see also Forbes story on same topic)
It seems that the EU has purchase the available supplies instead.
Spokesperson at Health and Human Services says
"We are confident that we will have 100 million doses of Pfizer’s vaccine as agreed to in our contract,” a spokesperson for Health and Human Services told Forbes, “and beyond that, we have five other vaccine candidates, including 100 million doses on the way from Moderna.”"
Other vaccine candidates? Which of these are likely to be anywhere near approval in the next few months?
Secretary Azar says that there will be enough vaccine for everybody in the second quarter of 2021
but no word on sources and supplies beyond the 100 million people (200 million doses) already contracted.
Discouraging.

#2
cyclotourist
Join Date: Jul 2002
Location: calgary, canada
Posts: 1,345
Mentioned: 2 Post(s)
Tagged: 0 Thread(s)
Quoted: 399 Post(s)
Liked 180 Times
in
112 Posts
Johnson and Johnson should be near the end of their phase III trials and I am not sure about the status of Astra Zeneca. They had announced results, but needed to do some more work on their stats, and they were starting another trial.
The problems right now seem to be supply chain and logistics, they will eventually get sorted out.
There are a whole pile of other vaccines out there in phase II or III trials, I expect we will see more successes but whether the others will be able to scale up to the numbers needed is another question.
The problems right now seem to be supply chain and logistics, they will eventually get sorted out.
There are a whole pile of other vaccines out there in phase II or III trials, I expect we will see more successes but whether the others will be able to scale up to the numbers needed is another question.

#3
Senior Member
Thread Starter
Join Date: Aug 2009
Location: Minneapolis
Posts: 3,644
Bikes: 2020 Salsa Warbird GRX 600, 2020 Canyon Ultimate CF SLX disc 9.0 Di2, 2020 Catrike Eola, 2016 Masi cxgr, 2011, Felt F3 Ltd, 2010 Trek 2.1, 2009 KHS Flite 220
Mentioned: 15 Post(s)
Tagged: 0 Thread(s)
Quoted: 2467 Post(s)
Liked 1,463 Times
in
881 Posts
But hard to understand why the Trump admin passed on the additional 500 million doses Pfizer offered them. Or rather, us. That would have been enough for all.

Likes For MinnMan:
#5
Senior Member
There will be enough. These big Pharmas can gear up 24-7 production lines and in addition license other big Pharmas to gear up 24-7 production of their particular formula. You don't want to be discarding expired batches that couldn't be used fast enough either. What you leave out is the roughly half the population that wouldn't accept a vaccine unless they were strapped down and anesthetized.

Likes For tyrion:
#7
A Roadie Forever
Join Date: Oct 2014
Location: Portland, OR
Posts: 9,271
Bikes: (2) ti TiCycles, 2007 w/ triple and 2011 fixed, 1979 Peter Mooney, ~1983 Trek 420 now fixed and ~1973 Raleigh Carlton Competition gravel grinder
Mentioned: 102 Post(s)
Tagged: 0 Thread(s)
Quoted: 2714 Post(s)
Likes: 0
Liked 1,176 Times
in
805 Posts
I thought good business was jumping in on an opportunity to get in on something early that everyone was going to want. And that our "CEO" might be a mediocre president but business was where he shone,
A million COVID-19 tests by April, Vaccines by elections. Vaccines soon for all. Have I been hallucinating?
A million COVID-19 tests by April, Vaccines by elections. Vaccines soon for all. Have I been hallucinating?

Likes For 79pmooney:
#8
cyclotourist
Join Date: Jul 2002
Location: calgary, canada
Posts: 1,345
Mentioned: 2 Post(s)
Tagged: 0 Thread(s)
Quoted: 399 Post(s)
Liked 180 Times
in
112 Posts
I think if you had a hundred million doses ready to go right now, many would be wasted because the logistics of vaccinating huge numbers in a short perioed of time haven't been worked out yet.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.

#9
Senior Member
Join Date: Mar 2010
Location: Seattle, WA
Posts: 21,544
Mentioned: 71 Post(s)
Tagged: 0 Thread(s)
Quoted: 13416 Post(s)
Liked 4,702 Times
in
2,641 Posts
There will be enough. These big Pharmas can gear up 24-7 production lines and in addition license other big Pharmas to gear up 24-7 production of their particular formula. You don't want to be discarding expired batches that couldn't be used fast enough either. What you leave out is the roughly half the population that wouldn't accept a vaccine unless they were strapped down and anesthetized.
Also I think children are last in line, they're less susceptance to getting sick and people seem to assume that means they spread it less too.

#10
Senior Member
Join Date: May 2014
Location: USA
Posts: 1,345
Mentioned: 7 Post(s)
Tagged: 0 Thread(s)
Quoted: 378 Post(s)
Liked 230 Times
in
177 Posts
An initial contracting for vaccine coverage for "the most-vital" portions of society (frontline healthcare workers, and the most-vulnerable in society) makes sense. So, X hundreds of millions of doses makes sense, for an initial arrangement.
Doesn't mean they'll cease production of it, if succeeding.
Just means the market will take over, at that point, and/or further contracting will be considered then.
Indeed, vaccine R&D groups aren't doing this for nothing. They're businesses and they're seeking to be compensated for their work. Same as anyone else. And so it makes sense to initiate their cycle with a vast infusion of cash and commitment up to a point, but then to allow them to go whole hog on their own once up and running. I suspect that so long as there's high demand for such vaccines, then such groups will continue production for years until the market forces begin changing things. (Same as with any other product.)
Doesn't sound like "stalling" to me, really. Just sounds like a two-phase approach: 1) initial funding for R&D and first run of product, given the urgency; followed by 2) ongoing normal-and-customary efforts in the open market.
Doesn't mean they'll cease production of it, if succeeding.
Just means the market will take over, at that point, and/or further contracting will be considered then.
Indeed, vaccine R&D groups aren't doing this for nothing. They're businesses and they're seeking to be compensated for their work. Same as anyone else. And so it makes sense to initiate their cycle with a vast infusion of cash and commitment up to a point, but then to allow them to go whole hog on their own once up and running. I suspect that so long as there's high demand for such vaccines, then such groups will continue production for years until the market forces begin changing things. (Same as with any other product.)
Doesn't sound like "stalling" to me, really. Just sounds like a two-phase approach: 1) initial funding for R&D and first run of product, given the urgency; followed by 2) ongoing normal-and-customary efforts in the open market.

#11
Senior Member
Join Date: Jun 2015
Location: Down Under
Posts: 1,854
Bikes: A steel framed 26" off road tourer from a manufacturer who thinks they are cool. Giant Anthem. Trek 720 Multiroad pub bike. 10 kids bikes all under 20". Assorted waifs and unfinished projects.
Mentioned: 9 Post(s)
Tagged: 0 Thread(s)
Quoted: 695 Post(s)
Liked 565 Times
in
296 Posts
An initial contracting for vaccine coverage for "the most-vital" portions of society (frontline healthcare workers, and the most-vulnerable in society) makes sense. So, X hundreds of millions of doses makes sense, for an initial arrangement.
Doesn't mean they'll cease production of it, if succeeding.
Just means the market will take over, at that point, and/or further contracting will be considered then.
Indeed, vaccine R&D groups aren't doing this for nothing. They're businesses and they're seeking to be compensated for their work. Same as anyone else. And so it makes sense to initiate their cycle with a vast infusion of cash and commitment up to a point, but then to allow them to go whole hog on their own once up and running. I suspect that so long as there's high demand for such vaccines, then such groups will continue production for years until the market forces begin changing things. (Same as with any other product.)
Doesn't sound like "stalling" to me, really. Just sounds like a two-phase approach: 1) initial funding for R&D and first run of product, given the urgency; followed by 2) ongoing normal-and-customary efforts in the open market.
Doesn't mean they'll cease production of it, if succeeding.
Just means the market will take over, at that point, and/or further contracting will be considered then.
Indeed, vaccine R&D groups aren't doing this for nothing. They're businesses and they're seeking to be compensated for their work. Same as anyone else. And so it makes sense to initiate their cycle with a vast infusion of cash and commitment up to a point, but then to allow them to go whole hog on their own once up and running. I suspect that so long as there's high demand for such vaccines, then such groups will continue production for years until the market forces begin changing things. (Same as with any other product.)
Doesn't sound like "stalling" to me, really. Just sounds like a two-phase approach: 1) initial funding for R&D and first run of product, given the urgency; followed by 2) ongoing normal-and-customary efforts in the open market.

#12
Society Dropout
Join Date: Jan 2018
Location: Hondo,Texas
Posts: 2,030
Bikes: Too many Motobecanes
Mentioned: 4 Post(s)
Tagged: 0 Thread(s)
Quoted: 1637 Post(s)
Liked 1,703 Times
in
1,082 Posts
I thought 5G was suppose to wipe out covid


#13
Senior Member
Join Date: Nov 2014
Location: Eugene, Oregon, USA
Posts: 24,968
Mentioned: 202 Post(s)
Tagged: 0 Thread(s)
Quoted: 13046 Post(s)
Liked 1,730 Times
in
1,309 Posts
I think if you had a hundred million doses ready to go right now, many would be wasted because the logistics of vaccinating huge numbers in a short perioed of time haven't been worked out yet.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.
The big problem will be handling. Storing at -80, then warming up and injecting. Are they individual vials, or small batch vials?
Hopefully the pharmaceutical companies have already been experimenting with long-term storage of similar mRNA vaccines. It is possible that if kept in ideal storage temperatures, they would last for quite some time.
My guess is that once the vaccine is finally available, there will be a big rush of people asking for it, especially elderly and vulnerable. Some areas will undoubtedly have a school mandate.

#14
genec
Join Date: Sep 2004
Location: West Coast
Posts: 26,676
Bikes: custom built, sannino, beachbike, giant trance x2
Mentioned: 47 Post(s)
Tagged: 0 Thread(s)
Quoted: 9687 Post(s)
Liked 1,956 Times
in
1,335 Posts
I think if you had a hundred million doses ready to go right now, many would be wasted because the logistics of vaccinating huge numbers in a short perioed of time haven't been worked out yet.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.
Warp speed project appears to have worked well, so far. Keep your fingers crossed that it will continue to do so.
Just ensuring "credit" goes where it is due... some folks like to "steal valor."

In their own recent announcements, Moderna gave Operation Warp Speed a nod, while Pfizer didn’t mention it. That can be explained by the different partnerships the Trump administration struck with the two companies.
The federal government’s deal with Pfizer would pay for the purchase of the company’s vaccine if it gets FDA emergency use authorization or approval. So Pfizer hasn’t gotten any Warp Speed funding yet. With Moderna and other companies, by contrast, the government is helping to fund the vaccines’ development and various efforts to scale up manufacturing.
The federal government’s deal with Pfizer would pay for the purchase of the company’s vaccine if it gets FDA emergency use authorization or approval. So Pfizer hasn’t gotten any Warp Speed funding yet. With Moderna and other companies, by contrast, the government is helping to fund the vaccines’ development and various efforts to scale up manufacturing.

#15
genec
Join Date: Sep 2004
Location: West Coast
Posts: 26,676
Bikes: custom built, sannino, beachbike, giant trance x2
Mentioned: 47 Post(s)
Tagged: 0 Thread(s)
Quoted: 9687 Post(s)
Liked 1,956 Times
in
1,335 Posts

Likes For genec:
#16
Society Dropout
Join Date: Jan 2018
Location: Hondo,Texas
Posts: 2,030
Bikes: Too many Motobecanes
Mentioned: 4 Post(s)
Tagged: 0 Thread(s)
Quoted: 1637 Post(s)
Liked 1,703 Times
in
1,082 Posts

#17
genec
Join Date: Sep 2004
Location: West Coast
Posts: 26,676
Bikes: custom built, sannino, beachbike, giant trance x2
Mentioned: 47 Post(s)
Tagged: 0 Thread(s)
Quoted: 9687 Post(s)
Liked 1,956 Times
in
1,335 Posts

And you have the right kinda beer... "cold." (best beer: free and cold)
Truth be told, I am particular about my beer... until someone hands me a free, cold one.

#18
Senior Member
Join Date: Nov 2014
Location: Eugene, Oregon, USA
Posts: 24,968
Mentioned: 202 Post(s)
Tagged: 0 Thread(s)
Quoted: 13046 Post(s)
Liked 1,730 Times
in
1,309 Posts
The honest truth is that Pfizer did not really benefit from "warp speed." They did this on their own dime.
Just ensuring "credit" goes where it is due... some folks like to "steal valor."
https://www.politifact.com/article/2...operation-war/
Just ensuring "credit" goes where it is due... some folks like to "steal valor."

https://www.politifact.com/article/2...operation-war/

#19
Society Dropout
Join Date: Jan 2018
Location: Hondo,Texas
Posts: 2,030
Bikes: Too many Motobecanes
Mentioned: 4 Post(s)
Tagged: 0 Thread(s)
Quoted: 1637 Post(s)
Liked 1,703 Times
in
1,082 Posts


#20
genec
Join Date: Sep 2004
Location: West Coast
Posts: 26,676
Bikes: custom built, sannino, beachbike, giant trance x2
Mentioned: 47 Post(s)
Tagged: 0 Thread(s)
Quoted: 9687 Post(s)
Liked 1,956 Times
in
1,335 Posts
I noticed the Pfizer contract seemed to be that they would only get paid if the vaccine was approved. So, if they made 250 million doses, and it flopped, they would be out all the money stocking up. Not a lot of incentive to start early (other than being the first off the block in a competitive potentially short-term market.

#21
Senior Member
The honest truth is that Pfizer did not really benefit from "warp speed." They did this on their own dime.
Just ensuring "credit" goes where it is due... some folks like to "steal valor."
https://www.politifact.com/article/2...operation-war/
Just ensuring "credit" goes where it is due... some folks like to "steal valor."

https://www.politifact.com/article/2...operation-war/
https://investors.pfizer.com/investo...2/default.aspx
Germany supplied the actual RnD money, half a billion, for the vaccine development through BioNTech. So it was still a government funded vaccine, just not the US government.
Last edited by billridesbikes; 12-09-20 at 04:18 PM.

#22
Senior Member
Join Date: Nov 2014
Location: Eugene, Oregon, USA
Posts: 24,968
Mentioned: 202 Post(s)
Tagged: 0 Thread(s)
Quoted: 13046 Post(s)
Liked 1,730 Times
in
1,309 Posts
And we may get a big chunk of the product that is made in the USA. But the product made in Europe will probably stay in Europe.
They still should be giving us the 100 million doses (50 million people) shortly, but then production may drop to a crawl.

#23
Senior Member
Join Date: Jul 2013
Location: NJ, USA
Posts: 580
Bikes: two blacks, a blue and a white.
Mentioned: 2 Post(s)
Tagged: 0 Thread(s)
Quoted: 145 Post(s)
Liked 206 Times
in
100 Posts
1. Pfizer didn't need the money, so why accept a lot of political entanglement? (read: government oversight)
2. A lot of people seem to ignore the fact that six firms are engaged in Warp Speed, not just two. When PFE and Moderna cross the line, the others don't just quit the race.
3. Some of these other vax candidates will be a lot easier to distribute. That makes them, in many ways, much more valuable than the mRNA solutions.
2. A lot of people seem to ignore the fact that six firms are engaged in Warp Speed, not just two. When PFE and Moderna cross the line, the others don't just quit the race.
3. Some of these other vax candidates will be a lot easier to distribute. That makes them, in many ways, much more valuable than the mRNA solutions.

#24
cyclotourist
Join Date: Jul 2002
Location: calgary, canada
Posts: 1,345
Mentioned: 2 Post(s)
Tagged: 0 Thread(s)
Quoted: 399 Post(s)
Liked 180 Times
in
112 Posts
The Sanofi vaccine had problems in phase 1/2 trials and is not proceeding with phase 3, until their vaccine is reformulated. That might actually put them out of the race.
If they do it that way, how are they going to get enough infections to get good statistics?
I am very interested to see results for the Jonson and Johnson vaccine, which are expected in January. It is one dose and doesn't need ultra refrigeration which should make it much easier to distribute.
I think this shows the value of all the competing techniques in the Warp Speed program. You simply don't know which are going to work until you try them. Better to have multiple candidates.
The problem relates to inadequate results in older adults in Sanofi’s Phase 1/2 trial, which the company traced back to an inadequate formulation of their vaccine, Su-Peing Ng, global medical head for Sanofi Vaccines, told STAT in an interview.
Ng said both Sanofi and GSK are committed to continuing work on the vaccine, and plan to begin a Phase 2b trial in February.
Ng said both Sanofi and GSK are committed to continuing work on the vaccine, and plan to begin a Phase 2b trial in February.
The vaccine’s path will be more challenging because of this delay; the Covid vaccine landscape is changing daily and placebo-controlled trials may not be feasible for much longer, with the first vaccines soon to be deployed. If people know they may soon have access to an authorized vaccine, there is less motivation to enroll in a trial where they might get a placebo.
https://www.statnews.com/2020/12/11/...id-19-vaccine/
Sanofi knows this and is proposing to the Food and Drug Administration that its Phase 2b trial compare its vaccine to one that is already authorized, not a placebo.
https://www.statnews.com/2020/12/11/...id-19-vaccine/
Sanofi knows this and is proposing to the Food and Drug Administration that its Phase 2b trial compare its vaccine to one that is already authorized, not a placebo.
I am very interested to see results for the Jonson and Johnson vaccine, which are expected in January. It is one dose and doesn't need ultra refrigeration which should make it much easier to distribute.
I think this shows the value of all the competing techniques in the Warp Speed program. You simply don't know which are going to work until you try them. Better to have multiple candidates.
Last edited by skookum; 12-11-20 at 08:15 PM. Reason: to add link
